BRAZILIAN JOURNAL OF PHARMACEUTICAL SCIENCES (ONLINE)

Visão geral
Metrics
Identidade
Ver todos

Qualis

B1

código do país

BR

tipo

journal

publicação venue de

3D-QSARpy: Combining variable selection strategies and machine learning techniques to build QSAR models. 59:1-12. 2023-01-01
Adolescente em cumprimento de medida socioeducativa em meio aberto. 15:95-109. 2023-01-01
An analysis of pharmaceutical care for critical patients of an adult Intensive Care Unit. 59:1-11. 2023-01-01
Analysis of reported adverse liver reactions associated with drugs used to treat patients with coronavirus disease 2019. 59:e21471. 2023-01-01
Antimalarials and macrolides: a review of off-label pharmacotherapies during the first wave of the SARS-CoV-2 pandemic. 59:1. 2023-01-01
Applicability of [18F]FDG/PET on the investigation of rosmarinic acid preconditioning efficacy in a global stroke model in mice.. 59:1-11. 2023-01-01
Applicability of an HPLC method for analysis of alcoholic and glycolic Brazilian green-propolis extracts. 59:e21972. 2023-01-01
Authentication of Brazilian Ginseng using Bar-HRM analysis. 59:e21179. 2023-01-01
BALB/c and C57BL/6 mouse strains influence gastric function outcomes with administration of cisplatin and dexamethasone. XX:XX-XX. 2023-01-01
Biological screening of herbal extracts and essential oil from Plectranthus species: α-amylase and 5-lipoxygenase inhibition and antioxidant and anti-Candida potentials. 59:1-16. 2023-01-01
COMPOUNDED DRUGS AS AN ALTHERNATIVE TO THE THERAPHEUTICAL GAPS OF INBORN ERRORS OF METABOLISM. 59:1-15. 2023-01-01
Cell phenotypes as activity biomarkers in patients with Systemic Lupus Erythematosus. 59:e20052. 2023-01-01
Chemical characterization, cytotoxicity, antimicrobial and antioxidant potential of Justicia pectoralis Jacq and Croton jacobinensis Baill extracts. 59:1-13. 2023-01-01
Cloroquina e COVID-19:uma análise sobre evidências, notícias e consumo em um Hospital Federal do Rio de Janeiro. 9:24534-24561. 2023-01-01
Consumption of benzylpenicillin as a syphilis control indicator. 59:1-9. 2023-01-01
Counterfeit medicines: relevance, consequences and strategies to combat the global crisis. 59:1. 2023-01-01
Cytotoxicity evaluation of haloperidol, clozapine and a new molecule with antipsychotic potential, PT-31, in NIH-3T3 cells. 59:1-14. 2023-01-01
Development and characterization of PLGA-Bupivacaine and PLGA-S75:R25 Bupivacaine (Novabupi®) biodegradable implants for postoperative pain. 58:1-10. 2023-01-01
Development and characterization of photoprotective nanoemulsions containing Babassu (Orbignya phalerata Mart.) lipophilic extract. 1:1-17. 2023-01-01
Development and clinical application of hydrogel formulations containing a papain and urea for wound healing. 59:1-18. 2023-01-01
Development and validation of an analytical method by HPLC-DAD for determination of caffeine in products based on guarana extracts (Paullinia cupana). 59:1-14. 2023-01-01
Development and validation of liquid chromatography-tandem mass spectrometry method to quantify dasatinib in plasma and its application to a pharmacokinetic study. 59:1-12. 2023-01-01
Development of a validated stability-indicating HPLC- DAD method for dasabuvir and the characterization of its degradation products using LC-QToF-MS/MS. 59:1-13. 2023-01-01
Development of inclusion complex based on cyclodextrin and oxazolidine derivative. 59:1-15. 2023-01-01
Development of metformin HCl granules using brown flaxseed mucilage as a retardant polymer: effects of polymer and drug ratio. 59:1. 2023-01-01
Development of microparticles and microparticulated tablets containing piperine. 59:1-13. 2023-01-01
ESTUDO EPIDEMIOLÓGICO DE ANSIEDADE EM ACADÊMICOS DA UNIVERSIDADE FEDERAL DE RONDÔNIA: AVALIAÇÃO DA MANIFESTAÇÃO DE SINTOMAS DE ANSIEDADE E FATORES SÓCIO DEMOGRÁFICOS EM ACADÊMICOS DA UNIVERSIDADE FEDERAL DE RONDÔNIA, PORTO VELHO. 27:93-108. 2023-01-01
Economic impact of pharmaceutical interventions in a medium complexity Brazilian university hospital. 58:1-12. 2023-01-01
Effect of polycaprolactone nanocapsules loaded with essential oils on biofilm formation by Staphylococcus aureus strains isolated from bovine mastitis cases. 59:1-13. 2023-01-01
Electrochemical immunosensing of low-density lipoprotein based on sol-gel encapsulation. 1:1-9. 2023-01-01
Encapsulation of benznidazole in nanostructured lipid carriers and increased trypanocidal activity in a resistant Trypanosoma cruzi strain. 59:.-17. 2023-01-01
Experimental acute anti-inflammatory activity of preparations with complexed cannabidiol in carriers. 59:1-19. 2023-01-01
FRANCHIN, Taísa Busaranho et al. Pharmacokinetics of isoniazid in Wistar rats exposed to ethanol.. 58:2541. 2023-01-01
HPLC-MS/MS method for determination of betamethasone in human plasma with application to a dichorionic twin pregnancy pharmacokinetic and placental transfers studies. 59:1. 2023-01-01
Health education can save the environment from medicine residues. 59:01-15. 2023-01-01
Hematological and coagulation parameters as predictors of death by Coronavirus disease in hospitalized patients: a Brazilian follow-up study. 59:1-12. 2023-01-01
Immunochromatography screening devices for cannabinoids in oral fluid sample. 59:1-17. 2023-01-01
Liquid chromatography-mass spectrometry for simultaneous determination of spironolactone and canrenone in plasma samples. 59:1-x. 2023-01-01
Locust bean gum hydrogels are bioadhesive and improve indole-3-carbinol cutaneous permeation: influence of the polysaccharide concentration. 59:1-15. 2023-01-01
Material educativo como apoio a assistência de gestantes HIV+ no pré-natal, parto e puerpério. 9:13219-13233. 2023-01-01
Mechanical, optical, and physicochemical properties of HPMC-based doxazosin mesylate orodispersible films .. 59:1-18. 2023-01-01
Microemulsions Improve Topical Protoporphyrin IX (PpIX) Delivery for Photodynamic Therapy of Skin Cancer. 59:1-18. 2023-01-01
Nephroprotective effects of Lippia sidoides ethanolic extract against ischemia/reperfusion-induced acute kidney injury. 59:1-15. 2023-01-01
Oral and nasal vaccination: current prospects, challenges, and impact of nanotechnology-based delivery systems. 59:1-16. 2023-01-01
Outpatient pharmaceutical office: access to medicines in public health. 59:1. 2023-01-01
PVP solid dispersions containing Poloxamer 407 or TPGS for the improvement of ursolic acid release. 59:1. 2023-01-01
Preformulation studies for the development of a microemulsion formulation from Ambrosia peruviana All., with anti-inflammatory effect. 59:1. 2023-01-01
Preservation of phenolic compounds on dried leaf infusion of Bauhinia forficata Link. 59:1-14. 2023-01-01
Process optimization of physicochemical properties of spray-dried Hydrocotyle umbellata L. extract. 59:1-15. 2023-01-01
Propyl (E) -3- (furan-2-yl) Acrylate: a synthetic antifungal potential with a regulatory effect on the biosynthesis of ergosterol in Candida Albicans. 59:1-14. 2023-01-01
Selective photodynamic effects on cervical adenocarcinoma cells provided by F127 Pluronic®-based micelles modulating hypericin delivery. 59:1-16. 2023-01-01
Solid-state properties of pink clay from Jequitinhonha Valley in Brazil for pre-formulation study. 59:000-13. 2023-01-01
Statistical process control of manufacturing tablets for antiretroviral therapy. 59:1-10. 2023-01-01
Synthesis, characterization and utilization of a new series of 1,2,3-triazole derivatives to neutralize some toxic activities of Bothrops jararaca snake venom. 58:1-16. 2023-01-01
University Pharmacy: from the foundation to the Pandemic times of Covid-19. 59:1-10. 2023-01-01
Use of bacaba peel for the development of hydroelectrolytic beverages and their consumer acceptance. 59:1-10. 2023-01-01
4-carvomenthenol, a monoterpene of essential oils, and its underlying effects on anti-inflammatory activity and immediate hypersensitivity reaction. 1:1-14. 2022-01-01
A novel approach to Cestrum intermedium (mata-boi): anatomical and physical-chemical characterization, in vitro biological activities, and metabolites of a Brazilian native species. 58:1-19. 2022-01-01
A study on 2-(2?-hydroxyphenyl) benzoxazoles derivatives as potential organic UV filters, Part I. 58:1-10. 2022-01-01
Action of Bromelain and Ficin on horse anti Bothrops sp venom Antibodies. 58:1-9. 2022-01-01
Acute Chagas Disease Caused by Trypanosoma cruzi TcIV and Transmitted by Panstrongylus geniculatus : Molecular Epidemiological Insights Provided by the First Documented Autochthonous Case in Rondônia, Southwestern Amazonia, Brazil. 22:244-251. 2022-01-01
Additive effect of the probiotics Lactobacillus exopolysaccharides and the Satureja calamintha extracts on enteropathogenic Escherichia coli adhesion. 58:1-15. 2022-01-01
Adverse events related to oral hormonal contraceptive use in undergraduate pharmacy students: a cross-sectional study. 58:1-12. 2022-01-01
Adverse reactions caused by antimicrobials in hospitalized pediatric patients: causality and avoidability analysis. 58:1-8. 2022-01-01
Aging-associated prostate smooth muscle hypercontractility in rats. 58:1. 2022-01-01
Analysis of Adherence to Fluoxetine Treatment through its Plasma Concentration. 58:1-10. 2022-01-01
Analysis of potential drug interactions in medical clinic sector in a Hospital of João Pessoa - PB. 58:1-7. 2022-01-01
Anti-Acanthamoeba castellanii activity of alkaloid-enriched extracts and lycorine from the Amaryllidaceae species. 58:e20459. 2022-01-01
Antibacterial effect of isoeugenol against Pseudomonas aeruginosa. 58:1-6. 2022-01-01
Anticholinesterase activity of β-carboline-1,3,5-triazine hybrids. 58:1-8. 2022-01-01
Antidepressant-like effect of caffeic acid: Involvement of the cellular signaling pathway. -:-. 2022-01-01
Antidepressant-like effect of caffeic acid: Involvement of the cellular signaling pathways. 58:1-7. 2022-01-01
Antimalarial activities of plants with medicinal potential: a systematic review of the literature. 11:e58311932389-1. 2022-01-01
Antimicrobial and Immunomodulatory Activities of Dried Extracts of Echinacea Purpurea. 58:1-8. 2022-01-01
Application of HACCP for development of quality risk management in a water purification system. 58:191051. 2022-01-01
Application of capillary zone electrophoresis to determine second-generation H1 antihistaminic drugs, loratadine and rupatadine. 58:1-9. 2022-01-01
Assessment of cytotoxicity, genotoxicity, and mutagenicity of the dexchlorpheniramine reference standard and pharmaceutical formula in human peripheral blood mononuclear cells. 58:1-8. 2022-01-01
Association between disease activity and quality of life among patients with rheumatoid arthritis. 58:e20626. 2022-01-01
Asymptomatic HIV-Infected Patients Present Blood Parameters Changed, According to Use of Therapy and the CD4+ T Cells Count. 58:--14. 2022-01-01
Behavioral characterization of ayahuasca treatment on Wistar rats in the open field test. 58:1-6. 2022-01-01
Biological activities of essential oils from Ocotea species. 58:e181097. 2022-01-01
Biological activities of essential oils from six genotypes of four Ocotea species. 27:1-11. 2022-01-01
Biological properties of Schinus terebinthifolia Raddi essential oil. 28:1-14. 2022-01-01
Bleeding associated with self-medication in warfarin users: A prospective observational study in Ijuí (Brazil). 58:1-8. 2022-01-01
CLINICAL PHARMACEUTICAL SERVICES IN THE PRIMARY HEALTH CARE OF THE FEDERAL DISTRICT. 58:e18593. 2022-01-01
CLINICAL PHARMACEUTICAL SERVICES OF PRIMARY HEALTHCARE OF THE FEDERAL DISTRICT: A DISCUSSION FROM THE SWOT MATRIX. 58:e18593. 2022-01-01
Calendula officinalis L. flower extract-mediated green synthesis of silver nanoparticles under LED light. 1:1-8. 2022-01-01
Captopril oral solution for pediatric use: formulation, stability study and palatability assessment in vivo. 58:--17. 2022-01-01
Cecropia pachystachya Trécul: a promising ingredient for skin-whitening cosmetics. 58:1-13. 2022-01-01
Chemical and biological properties of nordihydroguaiaretic acid. 58:1-11. 2022-01-01
Chemical composition and biological activity of essential oil of Baccharis erioclada DC.. 58:1-10. 2022-01-01
Chemical study of Adenocalymma axillarum crude leaf extract and isolated compounds.. 58:1-9. 2022-01-01
Chromatographic profile of xanthones and flavonoids in the anti-dengue extracts of Fridericia samydoides (Cham.) L.G. Lohmann (Bignoniaceae). 58:1-15. 2022-01-01
Chronic Lymphocytic Leukemia (CLL): evaluation of AKT protein kinase and microRNA gene expression related to disease pathogenesis.. 58:1-14. 2022-01-01
Circulating microparticles and thrombin generation in patients with Chronic Lymphocytic Leukemia. 58:1-13. 2022-01-01
Clinical pharmaceutical services in primary health care of the Federal District: Performance frequency and conditioning factors. 58:e20029. 2022-01-01
Clinical pharmaceutical services of primary health care of the Federal District: A discussion based on the SWOT matrix. 58:: e18593. 2022-01-01
Coagulase-negative staphylococci isolates from blood cultures of newborns in a tertiary hospital in southern Brazil. 58:1-10. 2022-01-01
Collaborative attitudes between pharmacists and physicians in Brazil. 58:1-7. 2022-01-01
Comparative study of cold hyperalgesia and mechanical allodynia in two animal models of neuropathic pain: different etiologies and distinct pathophysiological mechanisms.. 58:1-13. 2022-01-01
Comparator product issues for biowaiver implementation: the case of Fluconazole. 58:1-11. 2022-01-01
Comparison between DAS28-ESR and DAS28- CRPus for patients with rheumatoid arthritis: application in a population of southern Brazil. 58:1-5. 2022-01-01
Compatibility and efficiency of preservatives in emulsive cosmetic containing high content of surfactants. 58:1-9. 2022-01-01
Cord factor producer Mycobacterium abscessus subsp. bolletii in asymptomatic immunocompetent host sputa samples. 58:01-2. 2022-01-01
Coronavirus versus 70% Alcohol: Comments and Some Fundamental Definitions. 58:1-3. 2022-01-01
Curcuma longa extract protects against 5-fluorouracil-induced oral mucositis in hamsters. 2:1-15. 2022-01-01
Curcuma longa extract protects against 5-fluorouracil-induced oral mucositis in hamsters. 58:00-15. 2022-01-01
Current status of whitening agents and enzymes in Dentistry. 58:1-13. 2022-01-01
Cytotoxic activity of extracts from Tecoma species and isolated lignans. 58:1-1. 2022-01-01
Decline in Public Spending on Biopharmaceutics in Brazil. 58:1. 2022-01-01
Development and Characterization of a Hydrogel Containing Silver Sulfadiazine for Antimicrobial Topical Applications. Part II: Stability, Cytotoxicity and Silver Release Pattern. 58:1-23. 2022-01-01
Development and characterization of PLGA-Bupivacaine and PLGA-S75:R25 Bupivacaine (Novabupi®) biodegradable implants for postoperative pain. 58:1-10. 2022-01-01
Development and evaluation of topical formulations that contain hydroethanolic extract from Schinus terebinthifolia against HSV-1 infection. 58:1-11. 2022-01-01
Development and in vivo evaluation of lipid-based nanocarriers containing Jatropha isabellei dry extract from the dichloromethane fraction intended for oral treatment of arthritic diseases. 58:e19178-e19178. 2022-01-01
Development and validation of analytical methods by HPLC for quality control of avermectins and milbemycins in bulk samples. 58:1/58: e19587-13. 2022-01-01
Development of diethylcarbamazine-loaded poly(caprolactone) nanoparticles for anti-inflammatory purpose: Preparation and characterization. 58:1-9. 2022-01-01
Direct-acting antivirals for chronic Hepatitis C are effective and safe: an observational study in Londrina/PR. 58:1-6. 2022-01-01
Dissolution test for oral suspension: an overview about use and importance. 58:1-27. 2022-01-01
Distribution and antifungal susceptibility of Candida species isolated from clinical samples in southern Brazil. 58:e20727. 2022-01-01
Efavirenz dissolution enhancement V - A combined top down/bottom up approach on nanocrystals formulation. 58:1-14. 2022-01-01
Effect of non-nucleoside reverse transcriptase inhibitors and protease inhibitors on serum levels of myeloperoxidase and C-reactive protein in HIV-infected individuals. 58:1-10. 2022-01-01
Effectiveness of sunscreens and factors influencing sun protection: a review.. 1:1. 2022-01-01
Estimates Costs of Gastric Cancer in Central Brazil. 58:1-9. 2022-01-01
Evaluation of copaiba oil as enhancer of ibuprofen skin permeation. 58:1-10. 2022-01-01
Evaluation of miR-15a, miR-16-1, ZAP-70, Ang-2 and Bcl-2 as potential prognosis biomarkers in chronic lymphocytic leukemia. 58:1. 2022-01-01
Evaluation of miR-15a, miR-16-1, ZAP-70, Ang-2, and Bcl-2 as potential prognostic biomarkers in chronic lymphocytic leukemia. 58:1. 2022-01-01
Evaluation of pharmaceutical care in Brazilian primary health services settings: expanding objects and approaches. 58:e18733. 2022-01-01
Evaluation of the nutritional composition and antioxidant activity of Bjerkandera adusta. 58:1-9. 2022-01-01
Evaluation of the pharmacotherapeutic follow-up effectiveness in patients with dyslipidemia in the secondary health care in the Brazilian Unified Health System (SUS). 58:1-10. 2022-01-01
Evaluation of vitamin D and inflammatory markers in elderly. 58:1-11. 2022-01-01
Exopolysaccharides from Klebsiella oxytoca: anti-inflammatory activity. 58:1-11. 2022-01-01
Extended stability study of an extemporaneously analgesic solution of clonidine, ropivacaine and fentanyl. 58:1-14. 2022-01-01
Formaldehyde analysis of seized cosmetic products by HS-GC-MS of methylal, ethoxymethoxymethane, and ethylal derivatives. 58:e20253-9. 2022-01-01
Free acquisition of psychotropic drugs by the Brazilian adult population and presence on the National List of Essential Medicines. 58:1-6. 2022-01-01
Free interstitial levels of metformin in the liver of healthy and diabetic Wistar rats. 58:e19674. 2022-01-01
Glycemic control and associated factors in patients with type 1 diabetes mellitus in primary care in Southeastern Brazil. 58:e20985. 2022-01-01
Health benefits of Kombucha: drink and its biocellulose production. 58:e20766. 2022-01-01
Hospital readmission within 30 days of older adults hospitalized in a public hospital. 58:1-13. 2022-01-01
Hydroxymethylnitrofurazone (NFOH) decreases parasitaemia, parasitism and tissue lesion caused by infection with the Bolivia Trypanosoma cruzi type I strain in Swiss and C57BL/6 mice. 58:1-10. 2022-01-01
Hypertriglyceridemia promotes dysfunctions in high-density lipoprotein increasing the cardiovascular risk. 58:1-13. 2022-01-01
Improved antimutagenic effect of Pyrostegia venusta (Ker Gawl.) Miers nanostructured extract in liposome and polymeric nanoparticle. 5:1-12. 2022-01-01
In silico evaluation of potential drugs for the treatment of Colorectal Carcinoma. 58:e20343. 2022-01-01
In vitro and ex vivo antiplasmodial activity of 1-(3-benzyloxy-4-methoxy-phenyl)-3-(3,4,5-trimethoxy-phenyl)-propan-1-one) against circulating strains of Plasmodium spp. in the state of Rondônia, Brazil. 58:1-10. 2022-01-01
In vitro assessment for cytotoxicity screening of new antimalarial candidates. 58:1-11. 2022-01-01
In vitro evaluation of the cytotoxicity and eye irritation potential of preservatives widely used in cosmetics. 58:1-12. 2022-01-01
In vitro susceptibility of Sporothrix spp. to complexes coordinated with Co(II) and cobalt chloride hexahydrate. 58:---. 2022-01-01
Industry workers with hypertension and diabetes mellitus, the prevalence of self-reported adherence, and disease control. 58:1-13. 2022-01-01
Influence of additives on swelling and mucoadhesion properties of glyceryl monooleate liquid crystals.. 58:e20803. 2022-01-01
Influence of the ionic strength on the physicochemical properties of methotrexate-loaded chitosan polyelectrolyte complexes. 58:1-10. 2022-01-01
Innovation in Pharmaceutical Assistance. 58:e19724. 2022-01-01
Inorganic element profile of medicinal Cannabis extracts consumed by pediatric patients. 58:1-9. 2022-01-01
Interchangeability among carbamazepine formulations: the impact over epilepsy patients. 58:1-12. 2022-01-01
Involvement of MT2 receptors on protective effects of melatonin against gastrointestinal damage induced by cisplatin in mice. 58:1-10. 2022-01-01
Leaf extract of Coffea arabica L. reduces lipid peroxidation and has anti-platelet effect in a rat dyslipidemia model. 58:1-13. 2022-01-01
Mapping community pharmacy services in Brazil: a scoping review. 58:1-21. 2022-01-01
Medication errors in critical patients during medication reconciliation: analyses and clinical management. 58:2. 2022-01-01
Mupirocin ointments: In vitro x In vivo bioequivalence evaluation. 58:1-10. 2022-01-01
Muscle pain induced by static contraction is modulated by transient receptor potential vanilloid 1 and ankyrin 1 receptors. 1:20110. 2022-01-01
New and potential properties, characteristics, and analytical methods of ferulic acid: A review. 58:1-9. 2022-01-01
Off-label drug use in an adult intensive care unit of a Brazilian hospital. 58:e20238. 2022-01-01
Oral administration of eucalyptol reduces cell migration and pain-like behavior in zymosan-induced arthritis mice. 58:e21189. 2022-01-01
Patient safety culture from perspective of employees in a university hospital. 58:e20155. 2022-01-01
Patients? medication reconciliation in a university hospital. 58:1. 2022-01-01
Perception of pharmacists regarding human resources, training, and development of a national hospital pharmacy: a preliminary report on Basel Statements. 58:1-8. 2022-01-01
Perceptions of Pharmacy students about their competences for professional practice in community pharmacy.. 58:e18730-12. 2022-01-01
Persea americana Mill.: Evaluation of cytogenotoxicity and phytochemical prospection of leaf extracts. 58:1-10. 2022-01-01
Pharmaceutical Care Practice and Consequences on Quality of Life and Satisfaction of Diabetic Patients: A Randomized Clinical Trial. 58:1-11. 2022-01-01
Pharmaceutical Services in Primary Health Care: dissatisfaction among users, managers and pharmacists. 58:1-14. 2022-01-01
Pharmaceutical care and evaluation of adherence to antiretroviral therapy in people living with HIV/AIDS.. 58:1-13. 2022-01-01
Pharmaceutical care during COVID-19 pandemic: challenges and perspectives. 58:1-4. 2022-01-01
Pharmaceutical evaluation of compounded furosemide capsules and excipient performance. 58:20139-20155. 2022-01-01
Pharmacists? Educational Training and Professional Activities at the Municipal Level of the Brazilian National Health System. 58:e21323-e21334. 2022-01-01
Pharmacogenomics of mycophenolic acid in kidney transplantation: Contribution of immune response-related genes. 58:1. 2022-01-01
Pharmacokinetics of isoniazid in Wistar rats exposed to ethanol. 58:e18881. 2022-01-01
Pharmacological blockade of protease-Activated Receptor 2 improves airway remodeling and lung inflammation in experimental allergic asthma. 58:1-15. 2022-01-01
Pharmacovigilance: an evaluation on the practice of pharmacists acting in pharmacies and drugstores. 58:1-10. 2022-01-01
Physsicochemical characterization and cosmetic applications of Passiflora nitida Kunth leaf extract. 2022:1-14. 2022-01-01
Phytochemical profile, evaluation of antimicrobial and antioxidant activity in vitro of the hydroalcoholic extract of two species of the genus Cyperus (Cyperaceae). 1:1-14. 2022-01-01
Poloxamer-enhanced solubility of griseofulvin and its related antifungal activity against Trichophyton spp.. 58:1-13. 2022-01-01
Polymorphism in the pycrt-o and pvmdr-1 genes of Plasmodium vivax associated with a better prognosis for malaria. 39:421-427. 2022-01-01
Polystyrene-b-poly (acrylic acid) nanovesicles coated by modified chitosans for encapsulation of minoxidil. 58:e19106. 2022-01-01
Post-marketing sampling and testing programs for licensed medicinal products: a narrative review. 58:e19538. 2022-01-01
Potential interactions between psychotropic drugs and alcohol and tobacco dependence. 58:1-9. 2022-01-01
Potentially inappropriate medication use in a comprehensive therapy management service: clinical outcomes and interventions. 58:-. 2022-01-01
Preliminary prospection of phytotherapic compounds from the essential oils from barks and leaves of Umburana (Commiphora Leptophloeos). 58:e21609. 2022-01-01
Pretreatment with water kefir reduces the development of acidified ethanol-induced gastric ulcers. 1:1-10. 2022-01-01
Prevalence of Streptococcus agalactiae capsular types among pregnant women in Rio de Janeiro and the impact of a capsular based vaccine. 58:e20633. 2022-01-01
Prevalence of hypertension and obesity in patients with type 2 Diabetes Mellitus. 58:1-9. 2022-01-01
Profile of pharmaceutical interventions of a pharmacotherapeutic follow-up model for diabetic patients in a community pharmacy. 58:1-12. 2022-01-01
Progression of chronic kidney disease in non- dialysis patients: a retrospective cohort. 58:1-15. 2022-01-01
Proton pump inhibitor deprescription: A rapid review. 58:e19989. 2022-01-01
Psychoactive drugs in the Brazilian public health system: Use profile and associated factors. 58:1-11. 2022-01-01
RP-HPLC simultaneous quantification of rutin, avobenzone, and octyl methoxycinnamate in the presence of hydroxypropyl β-cyclodextrin (HPβCD) and sulfobutyl ether β-cyclodextrin (SBEβCD). 58:1-16. 2022-01-01
RP-HPLC simultaneous quantification of rutin, avobenzone, and octyl methoxycinnamate in the presence of hydroxypropyl β-cyclodextrin and sulfobutyl ether β-cyclodextrin. 58:1-16. 2022-01-01
Reflection about the hemodialysis water microbiological quality in Brazil. 58:1-13. 2022-01-01
Rising drug prices in Brazil during COVID-19 pandemic: another threat to people?s health. 58:e2086. 2022-01-01
Seasonal and pluviometric effects on the phenolic compound composition and antioxidant potential of Licania macrophylla Benth (Chrysobalanaceae), a medicinal plant from the Amazon rainforest. 58:1-15. 2022-01-01
Sensory Priming: The olfaction as an attention inducer. 5:1-151. 2022-01-01
Serum from morbidly obese patients affects melanoma cell behavior in vitro. 58:1-14. 2022-01-01
Single-center, retrospective study on changes in pain-relieving therapy after bone metastasis detection by bone scintigraphy in prostate cancer patients. 58:e191058. 2022-01-01
Small cell lung cancer: an overview of the targets. 58:1/12-12/12. 2022-01-01
Spending Estimates for Gastric Cancer in Central Brazil. 58:1-9. 2022-01-01
Starch-based orodispersible film for diclofenac release. 59:1-11. 2022-01-01
Supplementation with detox juice added with probiotic improves atherogenic parameters in healthy individuals. 58:1-11. 2022-01-01
Synthesis, characterization and utilization of a new series of 1,2,3-triazole derivatives to neutralize some toxic activities of Bothrops jararaca snake venom. 58:1-16. 2022-01-01
Tadalafil and Sildenafil illicit association: Stability- indicating HPLC method, photodegradation kinetic and toxicological studies. 58:1. 2022-01-01
Tetradenia riparia leaves, flower buds, and stem essential oils to control of Aedes aegypti larvae. 58:1-13. 2022-01-01
The Pharmacy of the Specialized Component of Pharmaceutical Policy of the 9th Regional Health Department of the State of Paraná and the Treatment of Ankylosing Spondylitis. 58:e19387. 2022-01-01
The ancient Tuberculosis in the novel COVID-19 scenario. 58:1-2. 2022-01-01
The clinical pharmacist?s role in a high-cost medicine pharmacy: Patient-centered care.. 58:e20301-8. 2022-01-01
The effects of pharmacist interventions on health outcomes in patients with advanced prostate cancer in Brazil. 58:1-11. 2022-01-01
The pharmacist?s role on transgender care: findings from a literature review. 58:01-09. 2022-01-01
Therapeutic drug monitoring of gabapentin: the applicability in patients with neuropathic pain. 58:1-9. 2022-01-01
Thrombolysis, clotting, and genotoxic activities modulated by essential oils extracted from Lippia alba. 58:1-11. 2022-01-01
Two-Step Purification of L-Asparaginase from Acrylaway® L. 58:1-12. 2022-01-01
Tyramine exerts hypolipidemic and anti-obesity effects in vivo. 58:1-20. 2022-01-01
Use of a mobile application for the control of anticoagulation with warfarin: a cluster randomized controlled clinical trial ? Ijui/RS/Brazil. 58:1-9. 2022-01-01
Use of biorelevant dissolution media in dissolution tests as a predictive method of oral bioavailability. 58:1-15. 2022-01-01
Use of medication and associated factors in adults living in Rio Branco, Acre. 58:19645-19. 2022-01-01
VALIDAÇÃO DA VERSÃO BRASILEIRA DO INSTRUMENTO DE AVALIAÇÃO DA QUALIDADE DE VIDA DA HEPATITE B - HBQOL, E SUA APLICAÇÃO A PACIENTES COM HEPATITE B CRÔNICA EM CASCAVEL - PR. 58:1-14. 2022-01-01
Validation of the Brazilian version of the hepatitis B quality of life evaluation instrument - HBQOL, and its application to patients with chronic hepatitis B in Cascavel - PR. 58:1-14. 2022-01-01
Vancomycin population pharmacokinetic modeling in children using Bayesian estimation and a Non Parametric Approach. 58:1-7. 2022-01-01
Vitamin C as a shelf-life extender in liposomes. 58:1-11. 2022-01-01
Antidiabetic activities of alkaloids isolated from medicinal plants. 57:00. 2021-01-01
Appropriate knowledge of the indications for medications in use among older individuals assisted in the Jornada Científica dos Acadêmicos de Farmácia-Bioquímica. 57:e19043. 2021-01-01
Assay of empagliflozin tablets by a stability-indicating micellar electrokinetic chromatography method and cytotoxicity study of degraded samples. 57:1-10. 2021-01-01
Barriers to access to medicines for non-communicable diseases for patients using the Brazilian Unified Health System (SUS). 57:e18016. 2021-01-01
Cell phenotypes as activity biomarkers of Systemic Lupus Erythematosus patients. 59:e20052. 2021-01-01
Characterization and identification of ascorbyl methylsilanol pectinate for cosmetic formulations application. 57:1-11. 2021-01-01
Chemical evaluation and anticholinesterase activity of Hippeastrum puniceum (Lam.) Kuntz bulbs (Amaryllidaceae). 57:1-10. 2021-01-01
Chronic and acute effects of kefir: the role of angiotensin converting enzyme inhibition instead of nitric oxide balance. 57:1-10. 2021-01-01
Curcumin supplementation in the treatment of patients with cancer: a systematic review. 57:1-14. 2021-01-01
DNA damage in a solution containing copper(II) ions and ascorbic acid: Effect of the presence of sulfite. 57:e181084-xxxx. 2021-01-01
Desirability Function in analytical method development for glitazones and metabolites determination employing HFLPME. 58:e19049. 2021-01-01
Development and validation of RP-HPLC method for simultaneous determination of lamivudine, stavudine, and zidovudine in perfusate samples: Application to the Single-Pass Intestinal Perfusion (SPIP) studies. 57:1/e19073-12. 2021-01-01
Drug interactions and adverse events in elderly heart disease patients. 57:1-8. 2021-01-01
Effectiveness and potential drug interactions in antiviral therapy for the treatment of chronic hepatitis C: real-life data from a specialized center in southern Brazil. 57:1-12. 2021-01-01
Effects of experimental conditions on solubility measurements for BCS classification in order to improve the biowaiver guidelines. 57:1-10. 2021-01-01
Evaluation of 1,5-Anhydroglucitol as a Biomarker for Type 2 Diabetes Mellitus in Patients without Overt Nephropathy. 57:e19078-7. 2021-01-01
Evaluation of the physicochemical and microbiological stability of liquid preparation from tizanidine hydrochloride tablets - a Hospital concern. 57:1-11. 2021-01-01
Impact of pharmacist intervention in patients with Alzheimer's disease. 58:---. 2021-01-01
In vitro susceptibility of Sporothrix spp. to complexes coordinated with Co(II) and cobalt chloride hexahydrate. 58:1-11. 2021-01-01
MULHERES VÍTIMAS DE VIOLÊNCIA: COMO OLHAR PARA UM ATENDIMENTO COM FRAGILIDADES. 8:9-21. 2021-01-01
Medication discrepancies in a hospital in Southern Brazil: the importance of medication reconciliation for patient safety. 57:e18064. 2021-01-01
Nanostructured lipid carriers as a novel tool to deliver sclareol: physicochemical characterisation and evaluation in human cancer cell lines. 57:1-15. 2021-01-01
New drugs registered in Brazil from 2003 to 2013: analysis from the perspective of child health. 57:.-15. 2021-01-01
Ocotea daphnifolia: phytochemical investigation, in vitro dual cholinesterase inhibition, and molecular docking studies. 57:e18310-10. 2021-01-01
Perceptions and use of medicinal plants by an elementary and high school community in Vila Velha, Espírito Santo, Brazil. 57:CC BY 4.0. 2021-01-01
Pharmacotherapy used for alcohol and cocaine use disorders in a CAPS-AD of Minas Gerais. 58:1. 2021-01-01
Potential prescribing omissions according to START criteria at the time of hospital discharge. 57:1-7. 2021-01-01
Potentially pathogenic bacteria isolated from neglected air and surfaces in hospitals. 57:--11. 2021-01-01
Preparation and characterization of liposomes loaded with silver nanoparticles obtained by green synthesis. 56:1-16. 2021-01-01
Profile of pharmaceutical care in primary health centers in São Bernardo do Campo, Southeastern Brazil. 57:1. 2021-01-01
Quality of Life of Elderly People Living in Different Types of Long-term Care Facilities. 58:1-9. 2021-01-01
Quinolinotriazole antiplasmodials via click chemistry: synthesis and in vitro studies of 7-Chloroquinoline-based compounds. 57:1-18. 2021-01-01
Relationship between corticotherapy and increased cardiac risk in patients with rheumatoid arthritis. 57:1-9. 2021-01-01
Sodium alendronate: proposal and reliability of indicators. 58:1-7. 2021-01-01
The influence of dehydroepiandrosterone on effector functions of neutrophils. 57:1-15. 2021-01-01
'Optimization of cosmetic formulations development using Box?Behnken design with response surface methodology: physical, sensory and moisturizing properties. 56:e18502. 2020-01-01
ANALYSIS OF THE PERCEPTION OF PUBLIC SCHOOL DISCOUNTS IN THE MUNICIPALITY OF PORTO VELHO ON SOLID WASTE AS AGRAVE IN THE CONTROL OF Aedes aegypt. SOUTH AMERICAN JOURNAL OF BASIC EDUCATION, TECHNICAL AND TECHNOLOGICAL. 7:336-350. 2020-01-01
AVALIAÇÃO ETNOBOTÂNICA DAS ESPÉCIES DAS FAMÍLIAS ASTERACEAE E LAMIACEAE UTILIZADAS COM POTENCIAL MEDICINAL NA REGIÃO DE PORTO VELHO - RONDÔNIA. 8:431-445. 2020-01-01
Anti-inflammatory activity and identification of the Verbena litoralis Kunth crude extract constituents. 56:01-8. 2020-01-01
Antibacterial substances from leaves of Protium spruceanum (Burseraceae): in vitro and in silico evaluation. 56:1-10. 2020-01-01
Application of capillary zone electrophoresis to determine second-generation H1 antihistaminic drugs, loratadine and rupatadine. --:--. 2020-01-01
Association between soluble biomarkers - microbial translocation, inflammation and cardiovascular risk in HIV- infected individuals: a systematic review. 56:1-11. 2020-01-01
Barriers to access to medicines for noncommunicable diseases for patients using the brazilian Unified Health System (SUS). 56:e18016. 2020-01-01
Bovine serum albumin-based nanoparticles containing the flavonoid rutin produced by nano spray drying. 56:.-8. 2020-01-01
Chemical composition and in vitro antibacterial activity of essential oils from Murraya paniculata (L.) Jack (Rutaceae) ripe and unripe fruits against bacterial genera Mycobacterium and Streptococcus. 56:1-9. 2020-01-01
Chemical composition, larvicidal and cytotoxic activity of Annona salzmannii (Annonaceae) seed oil.. 56:1-9. 2020-01-01
Chemical composition, phytotoxic potential, biological activities and antioxidant properties of Myrcia hatschbachii D. Legrand essential oil. 56:1-9. 2020-01-01
Comparative analyses of response surface methodology and artificial neural networks on incorporating tetracaine into liposomes.. 56:1-xx. 2020-01-01
Cost analysis of a medication dispensing service in community pharmacy in Brazil. 56:1-12. 2020-01-01
Determination of phenolic and triterpenic compounds in Jatropha gossypiifolia L by Ultra-high performance liquid chromatography-tandem mass spectrometric (UHPLC-MS/MS). 56:1-12. 2020-01-01
Diabetes as a risk factor of acute kidney injury in vancomycin users: an observational and prospective study'. 56:e1840-15. 2020-01-01
Economic model for obtaining cyclodextrins from commercial cgtase. 56:1-14. 2020-01-01
Enzymes modulation by dried grape pomace from the manufacture of wines and juices. 56:1-13. 2020-01-01
Equilibrium solubility study to determination of fexofenadine hydrochloride BCS class and challenges in establishing conditions for dissolution profiles applied to suspension. 56:1-10. 2020-01-01
Esculetin as bioactive marker: towards a rational scientific approach for the treatment of hyperuricemia using Traditional Chinese Medicine. 56:1-7. 2020-01-01
Estimated glomerular filtration rate and drug dose adjustment in patients in an intensive care unit in Brazil. 56:1-9. 2020-01-01
Ethanol extract of Cissampelos sympodialis ameliorates lung tissue damage in streptozotocin-induced diabetic rats. 56:1-9. 2020-01-01
Evaluation of the bioequivalence of two formulations containing the combination of 400 mg of acetaminophen (paracetamol), 4 mg of phenylephrine and 4 mg of chlorpheniramine in capsules: open-label, three-way crossover study, partially replicated in healthy volunteers of both sexes. 56:1-12. 2020-01-01
Evaluation of the stability of Polymyxin B in saline and glucose solutions using LC-MS/MS. 56:1-6. 2020-01-01
Extract of Solidago chilensis Meyen inflorescences: cytotoxicity and inhibitory activity on nitric oxide synthesis in activated macrophage cell line J774A.1. 56:1-7. 2020-01-01
Finasteride promotes worsening of the cardiac deleterious effects of nandrolone decanoate and protects against genotoxic and cytotoxic damage. 56:1-1. 2020-01-01
Gd-GLU toward NMR imaging: synthesis, characterization and breast cell uptake assay. 56:1-10. 2020-01-01
In vitro antifungal activity and phytochemical characterization of Eugenia uniflora, Libidibia ferrea and Psidium guajava.. 56:1-9. 2020-01-01
Influence of lipids and proteins amounts and pH values on the inhibitory effects of Origanum vulgare L. essential oil against Escherichia coli and Salmonella Typhimurium. 56:1-10. 2020-01-01
Is dialysis water a safe component for hemodialysis treatment in São Paulo State, Brazil?. 56:1-9. 2020-01-01
Is the efflux pump inhibitor Verapamil a potential booster for isoniazid against Mycobacterium tuberculosis?. 56:01-.. 2020-01-01
Laurus nobilis L.: assessment of the cytotoxic and genotoxic potential of aqueous extracts by micronucleus and Allium cepa assays. 56:1-9. 2020-01-01
Medication use by adults in greater Manaus: a population-based cross-sectional study, 2015. 56:e18756-e18757. 2020-01-01
Nephroprotective activity of the enriched polyphenol extract of Euterpe edulis Martius. 56:01-12. 2020-01-01
Nonadherence to treatment recommendations is a factor contributing to the clinical failure of daptomycin: Cohort study in Brazil. 56:7184. 2020-01-01
Novel Eudragit® -based polymeric nanoparticles for sustained release of simvastatin. 56:1-12. 2020-01-01
PLGA-corosolic acid implants for potential application in ocular neovascularization diseases. 56:1-13. 2020-01-01
POTENTIALLY INAPPROPRIATE MEDICATION USE IN A MEDICATION THERAPY MANAGEMENT SERVICE: CLINICAL OUTCOMES AND INTERVENTIONS. 56:1. 2020-01-01
Passiflora mucronata leaves extracts obtained from different methodologies: a phytochemical study based on cytotoxic and apoptosis activities of triterpenes and phytosterols constituents. 56:1-16. 2020-01-01
Passion fruit (Passiflora edulis) leaf extract modulates the oxidative metabolism of rat peritoneal neutrophils in a model of inflammation. 56:1-11. 2020-01-01
Pharmacovigilance of thalidomide in the Brazilian Health System and patient safety. 56:1-9. 2020-01-01
Phytochemical and morpho-anatomical study of the vegetative organs of Psychotria fractistipula L.B.Sm., R.M. Klein & Delprete (Rubiaceae). 56:1-9. 2020-01-01
Piroxican voltammetric determination by ultra low cost pencil graphite electrode. 56:1-6. 2020-01-01
Polymeric micelles containing resveratrol: development, characterization, cytotoxicity on tumor cells and antimicrobial activity. 1:1-13. 2020-01-01
Preparation and characterization of a novel antimicrobial film dressing for wound healing application. 56:1-11. 2020-01-01
Preparation and characterization of liposomes loaded with silver nanoparticles obtained by green synthesis. 56:1-16. 2020-01-01
Preparation of extemporaneous oral liquid in the hospital pharmacy. 56:1-15. 2020-01-01
Profile of activities developed by community pharmacists: do they corroborate the precepts of the pharmaceutical profession?. 56:1-8. 2020-01-01
Radiolabeling of cidofovir with technetium-99m and biodistribution studies. 56:1-9. 2020-01-01
Rapid identification of microbial contaminants in pharmaceutical products using a PCA/LDA based FTIR-ATR method. 57:e18899. 2020-01-01
Stability of hydroalcoholic extracts of two species of guaco; Mikania glomerata SPRENG. and Mikania laevigata SCHULTZ. (Asteraceae), by UHPLC-MS. 56:1. 2020-01-01
Stability-indicating HPLC method for determination of amiodarone hydrochloride and its impurities in tablets: a detailed forced degradation study. 56:1-9. 2020-01-01
Stability-indicating HPLC-DAD method for the simultaneous determination of fluoroquinolone in combination with a non-steroidal anti-inflammatory drug in pharmaceutical formulation. 56:1-11. 2020-01-01
Synergistic effect of ibuprofen with itraconazole and fluconazole against Cryptococcus neoformans. 56:18599-6. 2020-01-01
Synergistic effect of sertraline and disulfiram against multidrug resistant bacteria as a new alternative to drug repositioning. 56:1-6. 2020-01-01
Synthesis of novel papulacandin D analogs and evaluation of their antifungal potential. 56:1-8. 2020-01-01
Systematic review protocol: following PRISMA guide from Cochrane to generate evidence as treatment effect of pharmaceutical care for hypertension in primary care. 56:1-15. 2020-01-01
Tacinga inamoena vegetal drug characterization using phytochemistry, pharmacopoeial methods and thermoanalytical techniques. 56:1-8. 2020-01-01
Thrombolysis, clotting, and genotoxic activities modulation by essential oils from Lippia alba.. xx:1. 2020-01-01
Towards the cosmetic application of Passiflora coccinea (Aubl.): antioxidant activity and photo protective capacity of the methanolic and glycolic leaf extracts. 56:1-13. 2020-01-01
Urea incorporated into ordered mesoporous silica for potential cosmetic application. 56:1-14. 2020-01-01
VALIDATION OF A METHOD FOR SIMULTANEOUS ANALYSIS OF COCAINE, BENZOYLECOGNINE AND COCAETHYLENE IN URINE USING GAS CHROMATOGRAPHY-MASS SPECTROMETRY. 56:1-9. 2020-01-01
Validation of an analytical method by high-performance liquid chromatography and microbiological assay, biological safety and in silico toxicity for danofloxacin. 56:e18355. 2020-01-01
Validation of analytical method by LC. and microbiological assay, biological safety suites and in silicons toxicity for danofloxacin. 56:e18355. 2020-01-01

tem uma área de assunto

publisher

University of Sao Paulo

is open access

True invalid format

is in DOAJ

True invalid format